Application of glycyrrhizinic acid in treatment of patients with alcoholic liver disease

Application of glycyrrhizinic acid in treatment of patients with alcoholic liver disease

Aim of investigation. To estimate of clinical efficacy and safety profile of parenteral form of «Phosphogliv» preparation containing glycyrrhizin and essential phospholipids, at treatment of patients with alcoholic liver disease.Materials and methods. Overall 106 patients with chronic alcohol-induce...

Full description

Saved in:

Bibliographic Details
Main Authors:	I. G. Nikitin, I. Ye. Baykova, V. M. Volynkina, L. M. Gogova, G. I. Storozhakov, M. P. Prushkovskaya
Format:	Article
Language:	Russian
Published:	Gastro LLC 2009-02-01
Series:	Российский журнал гастроэнтерологии, гепатологии, колопроктологии
Subjects:	alcohol-induced liver disease tumor necrosis factor-α transaminases bilirubin abstinence
Online Access:	https://www.gastro-j.ru/jour/article/view/1602
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Chronic alcohol intoxication and liver diseases
by: A. I. Khazanov, et al.
Published: (2009-02-01)

Laboratory diagnostics of alcohol intoxication in patients with alcohol-induced liver disease
by: A. I. Pavlov, et al.
Published: (2010-02-01)

Application of ursodeoxycholic acid at non-alcoholic and alcohol-induced steatohepatitis
by: Ye. A. Fedos’ina, et al.
Published: (2010-06-01)

Association of alcohol abstinence with risk of hyperuricemia in rural Chinese adults: the Henan Rural Cohort Study
by: Xiaokang Dong, et al.
Published: (2025-02-01)

Effects of Resveratrol on Liver Function Tests in Patients with Non-Alcoholic Fatty Liver Disease: a Systematic Review and Meta-Analysis of Randomized Controlled Trials
by: P. Ebrahimpour, et al.
Published: (2024-03-01)

Algorithm of management of patient with alcohol-induced liver disease
by: M. V. Mayevskaya, et al.
Published: (2011-02-01)

Budesonide in treatment of alcohol-induced severe hepatitis: results of randomized trial
by: I. I. Komkova, et al.
Published: (2013-09-01)

New strategies in management of severe alcoholic hepatitis
by: P. Ye. Tkachenko, et al.
Published: (2015-10-01)

Efficacy of silymarinum at chronic diffuse liver diseases
by: A. V. Matvieiev, et al.
Published: (2011-09-01)

Clinical and morphological features of gastroduodenal pathology at alcohol-induced liver disease
by: I. V. Kozlova, et al.
Published: (2010-11-01)

Practical Aspects of Clinical Manifestations, Pathogenesis and Therapy of Alcoholic Liver Disease and Non-alcoholic Fatty Liver Disease: Expert Opinion
by: V. V. Tsukanov, et al.
Published: (2023-11-01)

Improvement of non-alcoholic fatty liver disease treatment
by: P. I. Seliverstov, et al.
Published: (2014-10-01)

Alcohol-induced liver disease: primary and secondary prevention
by: S. V. Plyusnin, et al.
Published: (2015-07-01)

Recent trends in studying of alcohol-induced liver disease
by: I. I. Komkova, et al.
Published: (2011-12-01)

Infiltration of the liver by cells of innate and adaptive immunity and their destruction in development of experimental immune concanavalin-A-induced hepatitis
by: S. I. Pavlovich, et al.
Published: (2011-12-01)

An Effect of Ursodeoxycholic Acid on Inflammation, Steatosis and Liver Fibrosis and Atherogenesis Factors in Patients with Non-Alcoholic Fatty Liver Disease: Results of the USPEH Study
by: M. V. Mayevskaya, et al.
Published: (2020-01-01)

The Role of the Microbiome and Intestinal Mucosal Barrier in the Development and Progression of Non-Alcoholic Fatty Liver Disease
by: T. S. Krolevets, et al.
Published: (2020-12-01)

Epidemiologic features of non-alcoholic fatty liver disease in Russia
by: O. M. Drapkina, et al.
Published: (2014-10-01)

Non-Alcoholic Fatty Liver Disease, Bile Acids and Intestinal Microbiota
by: R. V. Maslennikov, et al.
Published: (2018-09-01)

Structural and Functional Fundamentals of Alcoholic Disease
by: V. S. Paukov, et al.
Published: (2018-11-01)

Effect of weight loss on the course of non-alcoholic fatty liver disease: results of 6-month follow-up
by: L. V. Chesnokova, et al.
Published: (2015-03-01)

Outcomes of the toxic hepatites caused by alcohol surrogates
by: I. Yu. Pirogova, et al.
Published: (2013-12-01)

Liver and Nutrition. An Optimal Diet for Non-Alcoholic Fatty Liver Disease
by: M. V. Mayevskaya, et al.
Published: (2018-11-01)

Drug-Induced Liver Injuries (Clinical Guidelines for Physicians)
by: Vladimir T. Ivashkin, et al.
Published: (2019-03-01)

Alcohol, alcoholism and related consequences
by: M. V. Mayevskaya
Published: (2013-12-01)

Alcoholics Anonymous : the story of how many thousands of men and women have recovered from alcoholism /
Published: (2001)

Non-Alcoholic Fatty Liver Disease in Cardiac Patients with Overweight and Obesity
by: I. V. Logacheva, et al.
Published: (2019-01-01)

Asymptomatic elevation of serum aminotransferase activity: stages of diagnostic search
by: Yu. A. Tereshchenko, et al.
Published: (2014-07-01)

Drug Therapy for Non-Alcoholic Steatohepatitis-Induced Liver Fibrosis
by: D. V. Garbuzenko
Published: (2022-01-01)

Prevalence of non-alcoholic fatty liver disease in out-patients of the Russian Federation: DIREG 2 study results
by: V. T. Ivashkin, et al.
Published: (2015-12-01)

Clinical Practice Guidelines of the Russian Scientific Liver Society, Russian Gastroenterological Association, Russian Association of Endocrinologists, Russian Association of Gerontologists and Geriatricians and National Society for Preventive Cardiology on Diagnosis and Treatment of Non-Alcoholic Liver Disease
by: V. T. Ivashkin, et al.
Published: (2022-12-01)

Phenotypes of Non-Alcoholic Fatty Liver Disease in Different Regions of the Russian Federation, Diagnostic and Therapeutic Approach in Clinical Practice
by: V. T. Ivashkin, et al.
Published: (2023-08-01)

Risk of Cirrhosis in Patients with Non-alcoholic Fatty Liver Disease and Previous Viral Hepatitis B
by: S. N. Batskikh, et al.
Published: (2020-09-01)

Research progress of hypoxia-inducible factor-1α and zinc in the mechanism of diabetic kidney disease
by: Wei Qin, et al.
Published: (2025-02-01)

Hepatoprotection by L-Ornithine L-Aspartate in Non-Alcoholic Fatty Liver Disease
by: Roger F. Butterworth, et al.
Published: (2019-03-01)

Patient Management in Non-Alcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus
by: A. E. Bagriy, et al.
Published: (2021-06-01)

Antioxidants in the Treatment of Chronic Diffuse Liver Diseases (the Results of the “MAXAR” Observational Program)
by: M. V. Mayevskaya, et al.
Published: (2018-11-01)

Xiaohua Funing decoction ameliorates non-alcoholic fatty liver disease by modulating the gut microbiota and bile acids
by: Jindong Zhao, et al.
Published: (2025-02-01)

Supporting primary care clinicians in caring for patients with alcohol use disorder: study protocol for Records for Alcohol Care Enhancement (RACE), a factorial four-arm randomized trial
by: Kara M. Magane, et al.
Published: (2025-02-01)

Influence of Omega-3 and Green Tea Extract on Alcohol-Induced Liver Injury in Rats
by: Ridha Hassan Hussein, et al.
Published: (2018-07-01)